1
|
Danzinger S, Pöckl K, Kronawetter G, Pfeifer C, Behrendt S, Gscheidlinger P, Harrasser L, Mühlböck H, Dirschlmayer W, Schauer C, Reitsamer R, Uher H, Schönau K, Delmarko I, Singer CF. Axillary lymph node status and invasive lobular breast cancer : Analysis of the Clinical Tumor Register of the AGO Austria. Wien Klin Wochenschr 2023; 135:463-471. [PMID: 37010596 PMCID: PMC10497662 DOI: 10.1007/s00508-023-02162-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2022] [Accepted: 02/10/2023] [Indexed: 04/04/2023]
Abstract
BACKGROUND Invasive lobular carcinoma (ILC) represents the second most common type of invasive breast cancer (BC). Although ILC generally have good prognostic properties (positive estrogen receptor, ER, low tumor grade), they are generally diagnosed at a more advanced stage. The data on the axillary lymph node status in ILC compared to invasive ductal carcinoma (IDC) are considered controversial. Therefore, the aim of this study was to compare the pathological node stage (pN) between ILC and IDC in an Austria-wide register. METHODS Data of the Clinical Tumor Register (Klinisches TumorRegister, KTR) of the Austrian Association for Gynecological Oncology (AGO) were retrospectively analyzed. Patients with primary early BC, invasive lobular or ductal, diagnosed between January 2014 and December 2018, and primary surgery were included. A total of 2127 tumors were evaluated and compared in 2 groups, ILC n = 303, IDC n = 1824. RESULTS A total of 2095 patients were analyzed in the study. In the multivariate analysis, pN2 and pN3 were observed significantly more frequently in ILC compared with IDC (odds ratio, OR 1.93; 95% confidence interval, CI 1.19-3.14; p = 0.008 and OR 3.22; 95% CI: 1.47-7.03; p = 0.003; respectively). Other factors associated with ILC were tumor grades 2 and 3, positive ER, and pathological tumor stage (pT) 2 and pT3. In contrast, concomitant ductal carcinoma in situ, overexpression of the human epidermal growth factor receptor 2 (HER2), and a moderate and high proliferation rate (Ki67) were found less frequently in ILC. CONCLUSION The data show an increased risk of extensive axillary lymph node metastasis (pN2/3) in ILC.
Collapse
Affiliation(s)
- Sabine Danzinger
- Department of Obstetrics and Gynecology, Medical University of Vienna, Spitalgasse 23, 1090 Vienna, Austria
| | - Karin Pöckl
- Department of Obstetrics and Gynecology, Medical University of Vienna, Spitalgasse 23, 1090 Vienna, Austria
| | - Gerit Kronawetter
- Department of Obstetrics and Gynecology, Medical University of Vienna, Spitalgasse 23, 1090 Vienna, Austria
| | - Christian Pfeifer
- Department of Statistics, University of Innsbruck, Innsbruck, Austria
| | - Sandra Behrendt
- Department of Clinical Epidemiology, Tyrolean Federal Institute for Integrated Care, Tirol Kliniken GmbH, Innsbruck, Austria
| | - Patricia Gscheidlinger
- Department of Clinical Epidemiology, Tyrolean Federal Institute for Integrated Care, Tirol Kliniken GmbH, Innsbruck, Austria
| | - Lois Harrasser
- Department of Clinical Epidemiology, Tyrolean Federal Institute for Integrated Care, Tirol Kliniken GmbH, Innsbruck, Austria
| | - Helmut Mühlböck
- Department of Clinical Epidemiology, Tyrolean Federal Institute for Integrated Care, Tirol Kliniken GmbH, Innsbruck, Austria
| | - Walter Dirschlmayer
- Department of Obstetrics and Gynecology, Hospital Barmherzige Schwestern Ried, Ried im Innkreis, Austria
| | - Christian Schauer
- Department of Gynecology, Hospital Barmherzige Brüder Graz, Graz, Austria
| | - Roland Reitsamer
- Department of Gynecology, Paracelsus Medical University, University Hospital Salzburg, Landeskrankenhaus Salzburg, Salzburg, Austria
| | - Heidemarie Uher
- Department of Surgery, Breast Health Center, Hospital Landstraße, Vienna, Austria
| | - Kristina Schönau
- Department of General, Visceral and Tumor Surgery, Breast Health Center, Hospital Ottakring, Vienna, Austria
| | - Irmgard Delmarko
- Department of Clinical Epidemiology, Tyrolean Federal Institute for Integrated Care, Tirol Kliniken GmbH, Innsbruck, Austria
| | - Christian F. Singer
- Department of Obstetrics and Gynecology, Medical University of Vienna, Spitalgasse 23, 1090 Vienna, Austria
| |
Collapse
|
2
|
Danzinger S, Pöckl K, Kronawetter G, Pfeifer C, Behrendt S, Gscheidlinger P, Harrasser L, Mühlböck H, Dirschlmayer W, Schauer C, Reitsamer R, Uher H, Schönau K, Delmarko I, Singer CF. Axillärer Lymphknotenstatus beim invasiv lobulären
Mammakarzinom: eine Analyse des Klinischen TumorRegisters der
AGO. Geburtshilfe Frauenheilkd 2022. [DOI: 10.1055/s-0042-1746153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
Affiliation(s)
- S Danzinger
- Universitätsklinik für Frauenheilkunde, Medizinische
Universität Wien
- Universitätsklinik für Frauenheilkunde, Medizinische
Universität Wien
| | - K Pöckl
- Universitätsklinik für Frauenheilkunde, Medizinische
Universität Wien
| | - G Kronawetter
- Universitätsklinik für Frauenheilkunde, Medizinische
Universität Wien
| | - C Pfeifer
- Institut für Statistik, Universität
Innsbruck
| | - S Behrendt
- Institut für klinische Epidemiologie der Tirol Kliniken GmbH
(IET), Innsbruck
| | - P Gscheidlinger
- Institut für klinische Epidemiologie der Tirol Kliniken GmbH
(IET), Innsbruck
| | - L Harrasser
- Institut für klinische Epidemiologie der Tirol Kliniken GmbH
(IET), Innsbruck
| | - H Mühlböck
- Institut für klinische Epidemiologie der Tirol Kliniken GmbH
(IET), Innsbruck
| | - W Dirschlmayer
- Abteilung für Gynäkologie und Geburtshilfe, Krankenhaus
der Barmherzigen Schwestern Ried
| | - C Schauer
- Abteilung für Gynäkologie, Krankenhaus der Barmherzigen
Brüder Graz
| | - R Reitsamer
- Universitätsklinik für Frauenheilkunde und Geburtshilfe
der PMU, Landeskrankenhaus Salzburg
| | - H Uher
- Chirurgische Abteilung, Brustgesundheitszentrum, Klinik
Landstraße, Wien
| | - K Schönau
- Abteilung für Allgemein-, Viszeral- und Tumorchirurgie,
Brustgesundheitszentrum, Klinik Ottakring, Wien
| | - I Delmarko
- Institut für klinische Epidemiologie der Tirol Kliniken GmbH
(IET), Innsbruck
| | - C F Singer
- Universitätsklinik für Frauenheilkunde, Medizinische
Universität Wien
| |
Collapse
|
3
|
Danzinger S, Pfeifer C, Gscheidlinger P, Harrasser L, Kronawetter G, Behrendt S, Singer C. Lymphknotenstatus beim HER2-positiven Mammakarzinom und neoadjuvante Therapie. Geburtshilfe Frauenheilkd 2019. [DOI: 10.1055/s-0039-1693865] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
Affiliation(s)
- S Danzinger
- Universitätsklinik für Frauenheilkunde, Medizinische Universität Wien
| | - C Pfeifer
- Institut für Statistik, Universität Innsbruck
| | - P Gscheidlinger
- Institut für klinische Epidemiologie der Tirol Kliniken GmbH (IET), Innsbruck
| | - L Harrasser
- Institut für klinische Epidemiologie der Tirol Kliniken GmbH (IET), Innsbruck
| | - G Kronawetter
- Universitätsklinik für Frauenheilkunde, Medizinische Universität Wien
| | - S Behrendt
- Institut für klinische Epidemiologie der Tirol Kliniken GmbH (IET), Innsbruck
| | - C Singer
- Universitätsklinik für Frauenheilkunde, Medizinische Universität Wien
| |
Collapse
|